This is Thomas Sullivan - Policy & Medicine Writing Staff's Typepad Profile.
Join Typepad and start following Thomas Sullivan - Policy & Medicine Writing Staff's activity
Join Now!
Already a member? Sign In
Thomas Sullivan - Policy & Medicine Writing Staff
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
Physicians are fed up with ERH, and are organizing with campaigns and creative music videos such as Let Doctors Be Doctors. They have even created an infographic outlining the problems with electronic health records . The government finally seems to... Continue reading
Posted 6 hours ago at Policy and Medicine
Image
The February 2016 issue of Life Science Compliance Update, available here (subscription required), explores the impact technology has on the world of compliance departments and their operations. Issue Summary This issue brings many outside voices to the fray, writing on... Continue reading
Posted 6 hours ago at Policy and Medicine
Image
The United States House Oversight and Government Reform Committee held a hearing on developments in the prescription drug market. What was particularly interesting about this hearing, compared to past hearings on drug pricing and the current drug market, was that... Continue reading
Posted 3 days ago at Policy and Medicine
Image
In our latest endeavor to try to help you wade through the lengthy regulations known as Open Payments leading up to the March 31 submission deadline, we drafted the following article on the Final Submission and Attestation process. In order... Continue reading
Posted 4 days ago at Policy and Medicine
Image
Centers for Medicare and Medicaid Services is hosting an informal Question and Answer session on February 9, 2016, from 2:00 pm to 3:00 pm EST. During this Question and Answer session, members of the Open Payments team will be available... Continue reading
Posted 4 days ago at Policy and Medicine
Image
The International Committee of Medical Journal Editors (ICMJE) recently put forth a proposed set of new requirements for sharing data that was generated by interventional clinical trials. The ICJME believes there is an ethical obligation to responsibly share such data... Continue reading
Posted 5 days ago at Policy and Medicine
Image
The European Medicines Agency's (EMA) Management Board has adopted a new framework to govern interaction between the Agency and industry stakeholders. The framework covers interactions involving human and veterinary medicine, however there are still unanswered questions about specific products and... Continue reading
Posted 6 days ago at Policy and Medicine
Image
As we know all too well, the U.S. Food and Drug Administration (FDA) has long taken the position that a medical device or drug manufacturer who promotes an FDA-approved device or drug for any unapproved uses violates the Federal Food,... Continue reading
Posted Jan 31, 2016 at Policy and Medicine
Image
ProPublica, the same organization who brought us "Dollars for Docs" and the "Surgeon Scorecard," is once again making a foray into the medical transparency world. This time, they focus on the Health Insurance Portability and Accountability Act (HIPAA), and provide... Continue reading
Posted Jan 29, 2016 at Policy and Medicine
Image
We have previously drawn attention to some of the downsides of transparency as it relates to medical information. Those downsides typically revolve around the Sunshine Act and Open Payments data. However, there is another major concern about a yet another... Continue reading
Posted Jan 29, 2016 at Policy and Medicine
Image
We recently reported that 2015 resulted in the highest level of newly approved U.S. drugs in nineteen years. This reflects an industry-wide desire to research and develop drugs for rare and hard-to-treat diseases. As has been reported, while speaking at... Continue reading
Posted Jan 28, 2016 at Policy and Medicine
Image
On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni, United States Senate Finance Committee leadership, namely Senators Chuck Grassley (R-IA) and Ron Wyden (D-OR), have asked for public comments... Continue reading
Posted Jan 27, 2016 at Policy and Medicine
Image
The Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs final rule with comment on January 21, 2016. The rule addresses important areas of Medicaid drug reimbursement, as well as some of the changes that were made... Continue reading
Posted Jan 26, 2016 at Policy and Medicine
Image
The White House Office of Management and Budget released their 2016 rule agenda at the close of last year, laying out some of the goals they have for releasing final and proposed rules over the next year. In that agenda,... Continue reading
Posted Jan 25, 2016 at Policy and Medicine
Image
President Obama recently signed the Improving Regulatory Transparency for New Medical Therapies Act into law. The Act establishes time limits for Drug Enforcement Administration (DEA) actions on determining the proper category or schedule for drugs based on their potential for... Continue reading
Posted Jan 25, 2016 at Policy and Medicine
Image
We have long been vocal proponents of Continuing Medical Education (CME) and the benefits it provides to both the medical community and patients around the country. Recently, a study was published in the Journal of Outcome Measurement in Continuing Healthcare... Continue reading
Posted Jan 22, 2016 at Policy and Medicine
Image
Pharmaceutical and life sciences companies have long used detailing as a way to effectively communicate the benefits and features of a certain product to physicians. In 2008, the Washington, D.C. city council became the first legislative body in the country... Continue reading
Posted Jan 21, 2016 at Policy and Medicine
Image
As you may recall, we have previously written about ballot initiatives in California and Ohio that are attempting to provide relief from increasing drug prices. While the California measure has recently qualified for the ballot, the Ohio measure has recently... Continue reading
Posted Jan 21, 2016 at Policy and Medicine
Image
Breaking months of silence on Open Payments data, Centers for Medicare and Medicaid Services (CMS) updated some of the Open Payments data available on its website. CMS still plans to update the Open Payments data at least once a year... Continue reading
Posted Jan 20, 2016 at Policy and Medicine
Image
With the next filing period for spend data under the Sunshine Act coming up quickly, Ned Mumtaz and Brian Dahl are hosting a webinar on how to help you manage the risk of open payments and open payments reporting. The... Continue reading
Posted Jan 19, 2016 at Policy and Medicine
Image
Earlier this year the FDA announced its intention to issue a rule on fixed-dose combinations and co-packaged products. On December 23, FDA issued its proposed rule, with comments due by March 22, 2016. The rule outlines revisions to its regulations... Continue reading
Posted Jan 18, 2016 at Policy and Medicine
Image
Once again, the fact that the pharmaceutical industry helps financially support continuing medical education programs is in the spotlight. This time, the spotlight focuses on the College of Family Physicians of Canada (CFPC), where a small group of physicians are... Continue reading
Posted Jan 15, 2016 at Policy and Medicine
Image
During November's American Medical Association (AMA) House of Delegates (HOD) meeting in November, many resolutions and recommendations were adopted, some of which we have previously touched upon. In addition to the aforementioned HOD actions relating to price control measures on... Continue reading
Posted Jan 15, 2016 at Policy and Medicine
Image
The Accreditation Council for Continuing Medical Education (ACCME) has opened a public comment period for their recent proposal for a menu of new criteria for Accreditation with Commendation. This comment period is open until February 16, 2016 at 5:00 pm... Continue reading
Posted Jan 14, 2016 at Policy and Medicine
Image
The Department of Health and Human Services recently released their semi-annual regulatory agenda, a listing of rules the Department plans to issue in the foreseeable future. There are two separate lists, the shorter version in the Federal Register, and the... Continue reading
Posted Jan 14, 2016 at Policy and Medicine